by Philip S. Chen, Jr.* The National Institutes of Health, owing to its broad mandate to pursue and support acquisition of knowledge in biomedicine, is very much concerned with any investigations leading to better understanding of the causes and control of human diseases. One approach is to study health and illness in special subsets of the United States population and of populations in foreign countries.
In this paper, I shall touch briefly on a number of health problems and disease-oriented research topics looked at from the special perspective of Asian and Asian-American populations, hopefully to sensitize perceptions about the contributions that such studies can make to our total understanding of how best to achieve health and conquer disease.
The new goal of the World Health Organization (WHO) is "Health for all by the year 2000." "The aim is to enable all people of the world to attain an acceptable level of health and to lead a socially and economically productive life." (1) . Population Asia, with just over 20% of the world's land area, has over 55% of the world's population. The two most populous countries, China and India, alone account for over 40% of the world's population, and Indonesia is the fifth most populous nation, Japan is seventh, followed by Bangladesh and Pakistan.
An important factor in determining the health of a nation's population is the level of economic development, which in turn is related to the rate of population growth. Growth in population puts enormous pressures on many aspects of a nation's economy. The larger the number of infants and young children who need to be fed and cared for, the greater the number of those who will live in poverty, be uneducated, and underfed. An example of the contribution of traditional Chinese medicine to Western medical knowledge is the discovery of ephedrine through scientific studies of an old Chinese herbal concoction. Several decades ago, the Chinese-American pharmacologist, Dr. K. K. Chen, performed, in this country, 130 the work which led to the acceptance of ephedrine as a standard pharmaceutical agent.
I might add at this point a brief comment about the reported remarkable improvement in health care in the People's Republic of China, and the manner in which it was attained. Certain lessons can be learned from this which have applicability to other Asian countries as well as to the United States.
Soon after founding of the People's Republic of China, Chairman Mao issued four cardinal principles as guidelines for medical and health work in China. One was to stress prevention, another was to unite the practitioners of Chinese traditional medicine and of Western medicine. Today it is accepted that China has advanced considerably: in its health delivery system, using barefoot doctors, health aides, and midwives; in its medical education system; in its production of pharmaceuticals, medical instruments and apparatus; in its sanitation efforts, resulting in eradication or control of smallpox, cholera, plague, and venereal diseases; in its family planning programs; and in its integration of traditional medicine with modern Western practices.
Cancer
In a monumental study recently completed in the People's Republic of China, data on cancer mortality over the three-year interval [1973] [1974] [1975] The unavailability of special diets such as lowphenylalanine for patients with phenylketonuria is a problem. U. S. medical scientists, through visits to China, are helping to provide advice with respect to better diagnostic methods and treatment modalities for genetic diseases. As the general level of technology improves in the study of genetic diseases, there will undoubtedly be significant findings that will become evident owing to the very large and yet mostly homogeneous population in a country as large as China. The same can be said of other Asian countries.
Infectious Diseases
Most Asian populations do not differ from those in Western countries in their basic reactions to disease agents. However, a number of infectious diseases remain very serious problems in particular Asian populations, in contrast to the U.S. where they are rarely or never seen.
Parasitic Diseases
Malaria continues to be of global impact, especially in South Asia. In 1976 there were over 8 million cases. One of the serious problems today is falciparum malaria, resistant to chemotherapy. Considerable research efforts are aimed at immunologic approaches, i.e., the development of a vaccine. There is evidence that vaccines might be able to be produced from practically all stages of the parasite in man (sporozoites, schizonts, gametocytes, merozoites). One intriguing approach is to attempt to interrupt transmission, in effect by "vaccinating" the mosquito.
Transmitted by snails as a vector, Schistosomiasis has increased in incidence as a result of large- 
Radiation Exposure
One truly unique opportunity available only in Asia is the ability to study the long-term effects of radiation exposure in the atomic bomb survivors of Hiroshima and Nagasaki, Japan. Nowhere else in 132 the world is there such a population. A number of NIH staff, primarily from the NCI, but also from NIEHS and other institutes, have worked at the Radiation Effects Research Foundation (RERF) and its predecessor the Atomic Bomb Casualty Commission (ABCC).
The evidence that whole body irradiation can produce leukemia was firmly established by observations of the occurrence of acute and of chronic leukemia, both of which began to increase several years after the atomic bombs were dropped, peaking some 6 years later, but with continued higher incidence long afterwards. Prior to such direct observations on a large exposed population, the evidence for radiation-induced leukemia was based on individual case reports of early radiation workers or of radiologists, and experimental studies of the effects of x-rays in mice.
Despite the fact that their populations greatly exceed ours, the Asian countries have many of the same problems. Their 
